Methods for producing members of specific binding pairs
View Patent ↗A member of a specific binding pair (sbp) is identified by expressing DNA encoding a genetically diverse population of such sbp members in recombinant host cells in which the sbp members are displayed in functional form at the surface of a filamentous bacteriophage particle containing DNA encoding the sbp member, wherein the sbp member has a binding domain that consists of a dAb fragment. The displayed sbps may be selected by affinity with a complementary sbp member, and the DNA recovered from selected filamentous bacteriophage particles for expression of the selected sbp members.
1. A method for producing a binding molecule specific for a particular target epitope or antigen, which method comprises the steps of:
producing a population of filamentous bacteriophage particles displaying at their surface a population of binding molecules, wherein each binding molecule in the population of binding molecules has a binding domain and the population of binding molecules has a range of binding specificities, wherein the binding domain of the binding molecules consists of an antibody heavy chain variable domain with the structure of FR1-CDR1-FR2-CDR2-FR3-CDR3-FR4, and wherein each filamentous bacteriophage particle contains nucleic acid with a nucleotide sequence encoding the binding molecule expressed from the nucleic acid and displayed by the particle at its surface;
selecting for a filamentous bacteriophage particle displaying a binding molecule with a desired specificity by contacting the population of filamentous bacteriophage particles with a target epitope or antigen so that individual binding molecules displayed on filamentous bacteriophage particles with the desired specificity bind to said target epitope or antigen.
2. A method according to claim 1 wherein the binding molecules are synthetic.
3. A method according to claim 2 wherein nucleotide sequences encoding the binding molecules are provided by combining unrearranged V segments with D and J segments.
4. A method according to claim 1 wherein the nucleotide sequences encoding the binding molecules are derived by in vitro mutagenesis of an existing antibody coding sequence or pre-existing phage antibodies.
5. A method according to claim 1 wherein the nucleotide sequences encoding the binding molecules are derived from peripheral blood lymphocytes.
6. A method according to claim 1 wherein said nucleic acid is comprised in a phagemid genome within each filamentous bacteriophage particle.
7. A method according to any one of claims 1 to 6 additionally comprising separating bound filamentous bacteriophage particles from the target epitope or antigen.
8. A method according to claim 7 additionally comprising recovering separated filamentous bacteriophage particles displaying a binding molecule with the desired specificity.
9. A method according to claim 8 additionally comprising
producing in a recombinant system by expression from nucleic acid derived from said separated particles the binding molecule, or a fragment or derivative thereof with binding specificity for the target epitope or antigen, separate from filamentous bacteriophage particles.